Carole Ho
2020
In 2020, Carole Ho earned a total compensation of $4.3M as Chief Medical Officer at Denali Therapeutics, a 74% increase compared to previous year.
Compensation breakdown
| Bonus | $366,080 |
|---|---|
| Option Awards | $2,107,493 |
| Salary | $457,600 |
| Stock Awards | $1,382,774 |
| Other | $11,400 |
| Total | $4,325,347 |
Ho received $2.1M in option awards, accounting for 49% of the total pay in 2020.
Ho also received $366.1K in bonus, $457.6K in salary, $1.4M in stock awards and $11.4K in other compensation.
Rankings
In 2020, Carole Ho's compensation ranked 2,620th out of 13,090 executives tracked by ExecPay. In other words, Ho earned more than 80.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,620 out of 13,090 | 80th |
Division Manufacturing | 1,009 out of 5,621 | 82nd |
Major group Chemicals And Allied Products | 374 out of 2,254 | 83rd |
Industry group Drugs | 322 out of 1,954 | 84th |
Industry Biological Products, Except Diagnostic Substances | 85 out of 411 | 79th |
Source: SEC filing on April 22, 2021.
Ho's colleagues
We found three more compensation records of executives who worked with Carole Ho at Denali Therapeutics in 2020.
News
Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
April 19, 2022
Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
April 22, 2021
Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
April 22, 2020
Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
April 18, 2019